Author(s) Details:
Rajashri Namdev Kausdikar
Department of Pharmaceutical Chemistry, Appasaheb Birnale College of Pharmacy, Sangli, Maharashtra, India.
Manish S Kondawar
Department of Pharmaceutical Chemistry, Appasaheb Birnale College of Pharmacy, Sangli, Maharashtra, India.
Fahim J Sayyad
Department of Pharmaceutical Chemistry, Appasaheb Birnale College of Pharmacy, Sangli, Maharashtra, India.
This section is a part of the chapter: Mupirocin Emulgel: Formulation and Evaluation for the Management of Primary and Secondary Infections in Dry Skin Conditions
The general public frequently has dry skin. Dry skin is a common dermatosis affecting people of varying skin types and ages and various areas of the body. It is associated with both skin thickening and skin thinning and is triggered by both exogenous (e.g. climate, environment, lifestyle) and endogenous (e.g. medication, hormone fluctuations, organ diseases) factors. Erythema, oedema, exudation, and crusting are signs of an inflammatory reaction when dry skin is present together with chapping or underlying dermatoses. The most common skin conditions where dry skin may be a symptom include ichthyosis, psoriasis, and dermatitis/eczema. Primary and secondary infections can occur in these conditions. When it comes to treatment, secondary skin infections like dermatoses in atopic dermatitis, psoriasis, and wounds that get infected are worse than the original infections.
How to Cite
Kausdikar, R. N. ., Kondawar, M. S. ., & Sayyad, F. J. . (2025). Mupirocin Emulgel: Formulation and Evaluation for the Management of Primary and Secondary Infections in Dry Skin Conditions. Pharmaceutical Science: New Insights and Developments Vol. 4, 62–76. https://doi.org/10.9734/bpi/psnid/v4/4713